Bristol-Myers Squibb and Samsung BioLogics Announce Biopharmaceutical Manufacturing Relationship

News   Jul 31, 2013

 
Bristol-Myers Squibb and Samsung BioLogics Announce Biopharmaceutical Manufacturing Relationship
 
 
 

RELATED ARTICLES

CMC Biologics Announces Development and Manufacturing Agreement with Harpoon Therapeutics

News

Companies have entered into agreement for the development and manufacturing of three TriTAC molecules for the treatment of cancers.

READ MORE

Serialization Capabilities Now Operational at Lonza Edinburgh Facility for Liquid-Filled Hard Capsules

News

Investment in former Capsugel site improves anti-counterfeiting security for Lonza’s global supply chain.

READ MORE

Changes Identified in Body Cells During Type2 Diabetes Onset

News

Researchers have found fresh evidence to explain the processes that occur in the body’s cells leading to the onset of type2 diabetes. Utilising metabolomics, results showed that amino acids play a contributory role in the onset of type2 diabetes in some younger and older patients, as the metabolism of specific amino acids is adversely affected.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Analysis & Separations

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE